Christopher Ryan Sullivan

Chief Financial Officer

Chief Financial Officer at Avalo Therapeutics, Inc., filing insider transactions between 2026-08-17 and 2026-09-16.

Total Purchases

—

0 transactions

Total Sales

$1.8M

5 transactions

Companies Traded

5 total filings

Active Since

2026-08-17

Last: 2026-09-16

Companies

Avalo Therapeutics, Inc.

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-09-16	AVTX	Sale	12.4K	$16.33	$202K	39.9K	SEC ↗
2026-09-10	AVTX	Sale	10.2K	$17.62	$179K	39.9K	SEC ↗
2026-08-18	AVTX	Sale	31.0K	$20.05	$622K	39.9K